A Thorough Corrected QT Interval Trial

Trial Profile

A Thorough Corrected QT Interval Trial

Phase of Trial: Phase I

Latest Information Update: 14 Apr 2015

At a glance

  • Drugs Pemafibrate (Primary) ; Moxifloxacin
  • Indications Dyslipidaemias
  • Focus Pharmacodynamics
  • Sponsors Kowa Research Institute
  • Most Recent Events

    • 09 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 05 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top